A recent study has revealed a significant disparity between patient preference and actual uptake of long-acting injectable antiretroviral therapy (LAI-ART) for HIV treatment. Despite a reported preference among many individuals living with HIV for this innovative treatment modality, the number of patients actually utilizing LAI-ART remains surprisingly low. This finding is particularly noteworthy given the potential benefits of injectable ART, which offers an alternative to daily oral medication. For many, the prospect of receiving an injection periodically, rather than remembering to take pills every day, is highly appealing. It can reduce the burden of daily medication management, potentially improve adherence, and offer a greater sense of normalcy and privacy. However, the study indicates that these expressed preferences are not translating into widespread adoption. Several factors could be contributing to this gap. Access to LAI-ART might be limited due to geographical constraints, cost, or availability of healthcare providers trained in administering these injections. There may also be a lack of awareness or understanding about the treatment among both patients and some healthcare professionals. Stigma associated with injectable treatments, or concerns about the injection process itself, could also play a role. Furthermore, the study might not have fully captured the nuances of patient decision-making, which can be influenced by a complex interplay of individual circumstances, physician recommendations, and insurance coverage. The implications of this low uptake are important for public health efforts aimed at controlling HIV. Increased adherence to antiretroviral therapy is crucial for viral suppression, which not only improves individual health outcomes but also significantly reduces the risk of HIV transmission. If LAI-ART offers a viable solution for improved adherence for a segment of the patient population, then addressing the barriers to its use is paramount. Further research is needed to pinpoint the exact reasons for this discrepancy and to develop targeted strategies to bridge the gap between preference and practice. This could involve educational initiatives for patients and providers, streamlining access to treatment, and addressing any potential concerns or misconceptions surrounding LAI-ART. Ultimately, ensuring that patients can access and benefit from the most suitable treatment options available is a key goal in HIV care.